Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Revenue

Syndax Pharmaceuticals had revenue of $64.86M in the quarter ending March 31, 2026, with 223.64% growth. This brings the company's revenue in the last twelve months to $217.42M, up 397.28% year-over-year. In the year 2025, Syndax Pharmaceuticals had annual revenue of $172.35M with 627.84% growth.

• Revenue (ttm): $217.42M
• Revenue Growth: +397.28%
• P/S Ratio: 7.92
• Revenue / Employee: $728,772
• Employees: 298
• Market Cap: 1.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	172.35M	148.67M	627.84%
Dec 31, 2024	23.68M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	139.71M	138.19M	9,109.56%
Dec 31, 2020	1.52M	-	-
Dec 31, 2019	1.52M	-	-
Dec 31, 2018	1.52M	-591.00K	-28.04%
Dec 31, 2017	2.11M	888.00K	72.79%
Dec 31, 2016	1.22M	593.00K	94.58%
Dec 31, 2015	627.00K	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 18, 2026

Data Sources Report a data error